Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alendronate-conjugated liposome for targeting of osteoblastic prostate cancer: evaluation of binding to bone matrix and <i>in vivo</i> targeting in a mouse model.

Journal of drug targeting·2026
Same author

Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironment.

Prostate cancer and prostatic diseases·2025
Same author

KDM4A promotes NEPC progression through regulation of MYC expression.

Cancer letters·2025
Same author

Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care.

Cancers·2025
Same author

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jul 7, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Current trials using bone-targeting agents in prostate cancer.

Shi-Ming Tu1, Sue-Hwa Lin

  • 1Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. stu@mdanderson.org

Cancer Journal (Sudbury, Mass.)
|February 28, 2008
PubMed
Summary
This summary is machine-generated.

Prostate cancer bone metastasis involves complex cell interactions. Targeting cancer stem cells and their unique microenvironment may offer novel therapeutic strategies for this challenging disease.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Experiment Videos

Last Updated: Jul 7, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Area of Science:

  • Oncology
  • Cancer Metastasis Research
  • Bone Biology

Background:

  • Prostate cancer frequently metastasizes to bone, significantly impacting patient prognosis.
  • Bone metastasis in prostate cancer is predominantly osteoblastic, involving interactions between cancer cells, osteoblasts, and osteoclasts.
  • Current treatments target bone cells (osteoblasts/osteoclasts) or associated vasculature, but novel approaches are needed.

Purpose of the Study:

  • To explore novel concepts regarding the mechanisms of prostate cancer bone metastasis.
  • To propose a refined "seed and soil" model for understanding prostate cancer bone metastasis.
  • To identify potential new therapeutic targets beyond current treatment strategies.

Main Methods:

  • Review and synthesis of existing literature on prostate cancer bone metastasis.
  • Conceptual framework development based on "seed and soil" hypothesis.
  • Speculative analysis of cancer stem cells and the bone microenvironment ('onco-niche').

Main Results:

  • Prostate cancer bone metastasis is a complex process involving interactions between cancer cells and the bone microenvironment.
  • The "seed" in prostate cancer bone metastasis may involve cancer stem cells.
  • The "soil" may represent a specific bone microenvironment, termed an 'onco-niche', supporting cancer stem cell survival and growth.

Conclusions:

  • Understanding the specific cellular and microenvironmental interactions is crucial for effective prostate cancer bone metastasis treatment.
  • Targeting cancer stem cells or the bone 'onco-niche' presents a promising new therapeutic avenue.
  • This refined "seed and soil" model offers a novel perspective for advancing treatment strategies for prostate cancer bone metastasis.